Intech Investment Management LLC Cardiff Oncology, Inc. Transaction History
Intech Investment Management LLC
- $9.39 Billion
- Q1 2025
A detailed history of Intech Investment Management LLC transactions in Cardiff Oncology, Inc. stock. As of the latest transaction made, Intech Investment Management LLC holds 31,074 shares of CRDF stock, worth $105,962. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,074
Previous 18,266
70.12%
Holding current value
$105,962
Previous $79,000
22.78%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CRDF
# of Institutions
124Shares Held
29MCall Options Held
900KPut Options Held
234K-
Commodore Capital LP New York, NY5.38MShares$18.4 Million1.66% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.12MShares$10.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.63MShares$8.96 Million0.0% of portfolio
-
Blair William & CO Chicago, IL1.75MShares$5.97 Million0.02% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA1.45MShares$4.93 Million0.01% of portfolio
About Cardiff Oncology, Inc.
- Ticker CRDF
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,334,900
- Market Cap $148M
- Description
- Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...